Cell therapy is an active area of immunological research and represents a highly innovative and rapidly expanding sector of the pharmaceutical industry. CiMaas is part of the the INsTRuCT Consortium (www.instruct-h2020.eu) which comprises 15 different European companies or universities from 8 Member States, that answers an unmet need for postdoctoral researchers trained in scientifically excellent research and cell therapy development.
On Saturday January 11, 2020, CiMaas appeared in a special program on new innovations in medicine. It is part of a production for the RTL-Z program " How it's done". Broadcast time is 17.00.
Saturday April 11 at 16.30; April 14 at 10:30 uur and April 16 at 16:30 the programme will be repeated
Kiadis and CiMaas, Dutch developers and producers of cell therapy for cancer, have now signed an agreement to co-develop a fast and efficient production process to generate high numbers of Natural Killer Cells with strong capacity to kill tumor cells.